Emma Halligan found connection at a free New Jersey retreat for women with cancer, which held its annual walk and 5K on Oct.

Twenty-four years after breast cancer, one survivor reflects on mammogram anxiety, the relief of clear results and the ...

Eileen Carter was told she had two to three years to live after a stage 4 breast cancer diagnosis. A second opinion changed ...

In a randomized trial of nearly 100,000 women in Germany, 3D mammography found a larger share of breast cancers at the ...

The U.S. Food and Drug Administration (FDA) has granted accelerated approval to Jemperli (dostarlimab) for adults with stage ...

Chester Freeman reflects on hiding the scars from his childhood tumor surgeries for decades and finally feeling comfortable ...

Depending on dose, firmonertinib shrank tumors in 43% to 68% of patients as a first treatment for EGFR PACC-mutant lung ...

In this episode of CURE’s Cancer Search Bar, psycho-oncologist Ramy Sedhom, section chief of oncology and palliative care and co-leader of psychosocial oncology services at Penn Medicine Princeton ...

Five colorectal cancer trials recently began treating patients, testing targeted drugs, bispecific antibodies and ...

The trial added 177Lu-PNT2002 to stereotactic body radiation therapy (SBRT) and found that median progression-free survival ...

Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch. Beyond the headline Presidential Symposium sessions, ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, ...